PCLO.V - PharmaCielo Ltd.

TSXV - TSXV Delayed Price. Currency in CAD

PharmaCielo Ltd.

1 Toronto Street
Suite 805
Toronto, ON M5C 2E3
Canada
416 315 8741
http://www.pharmacielo.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. David AttardCEO & Director92.61kN/A1973
Mr. Scott LaitinenChief Financial Officer475.93kN/A1964
Mr. David GordonChief Corp. Officer125.41kN/A1964
Mr. Anthony W. WileSpecial Consultant273.84kN/AN/A
Mr. Henning von KossPres & DirectorN/AN/A1962
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts, tetrahydrocannabinol, and related products to pharmacies, medical clinics, and cosmetic companies. The company also offers telemedicine software. It serves in Canada, Colombia, Italy, and Mexico. PharmaCielo Ltd. is headquartered in Toronto, Canada.

Corporate Governance

PharmaCielo Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.